BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FIRST QUARTER 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Boston Scientific (BSX) Reports In-Line Q1 EPS
April 27, 2022 6:34 AM EDTBoston Scientific (NYSE: BSX) reported Q1 EPS of $0.39, in-line with the analyst estimate of $0.39. Revenue for the quarter came in at $3.03 billion versus the consensus estimate of $2.95 billion.
GUIDANCE:
Boston Scientific sees Q2 2022 EPS of $0.41-$0.43. Boston Scientific sees Q2... More
